Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy

Barber, James; Tressler, Terry; Willis, Gregory S.; Martínez, Francisco; Peisner, David B.; Goodman, Jay D.; Taboada, Claudia

doi:10.1016/j.ajog.2011.01.001

Cited by 26 publications

(14 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other rare morbidities including fistula and arteriovenous fistula formation were also reported in this series and by other authors. [25][26][27] An empty uterus was obtained spontaneously in 75% of cases after a median of 13.5 weeks (range, 4-60 weeks). 2 The results of this large study suggest that it is possible for centers with limited experience in conservative treatment of PAS disorders to attempt to preserve the uterus by leaving the placenta in situ, but it is essential that these centers have emergency access to blood products, obstetric anesthesia, interventional radiology, urology, and gynecological oncology expertise.…”

Section: "Leaving the Placenta In Situ" Approachmentioning

confidence: 99%

FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,

Sentilhes

Kayem

Chandraharan

et al. 2018

Intl J Gynecology & Obste

248

246

View full text Add to dashboard Cite

Section: "Leaving the Placenta In Situ" Approachmentioning

confidence: 99%

FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,

Sentilhes

Kayem

Chandraharan

et al. 2018

Intl J Gynecology & Obste

248

246

View full text Add to dashboard Cite

“…Finally, although conservative treatment seems preferable for placenta percreta with invasion of the adjacent organs , the least morbid management for placenta accreta or percreta without such invasion remains open. Practices in France differ from those in the USA where a cesarean hysterectomy is the standard recommendation .…”

Section: Management Of Placenta Accreta Suspected Before Deliverymentioning

confidence: 99%

PACCRETA: Clinical situations at high risk of Placenta ACCRETA/Percreta: impact of diagnostic methods and management on maternal morbidity

Kayem

Deneux‐Tharaux

Sentilhes

2013

Acta Obstet Gynecol Scand

View full text Add to dashboard Cite

Background. No population-based study has assessed the prevalence of placenta accreta, the predictive value of prenatal diagnostic examinations, the maternal morbidity associated with its management, or its psychological effects. Moreover, the technical resources necessary for the safest delivery of women at risk have not been clearly identified. Objectives. The primary objectives are to identify individual risk factors, as well as factors associated with types of management and with the healthcare facilities for postpartum hemorrhage. Secondary objectives are to (i) determine the prevalence of placenta accreta among women at risk; (ii) assess the predictive value of ultrasound and MRI for the diagnosis of placenta accreta in this population; (iii) evaluate psychological impact and physical complications; and (iv) report maternal physical complications during the year after delivery. Design. Population-based prospective observational study of pregnant women with a placenta inserted at a uterine scar. Setting. A total of 182 centers in eight French regions, with 270 000 deliveries annually. Methods. We expect to include 620 women at risk of placenta accreta in two years, of whom approximately 120 (20%) will have placenta accreta. Main outcome measures. The primary outcome measure is severe maternal hemorrhage; secondary outcome measures are maternal morbidity and deaths, predictive value of ultrasound and MRI, and psychological evaluations at 6 and 12 months. Conclusion. This study will be the first prospective population-based study to include women at risk of placenta accreta and to investigate incidence, prenatal detection, type of management, morbidity and maternal psychological consequences.

show abstract

“…Notably, conservative management was inconsistent among respondents 1 . Sixty‐one articles were retrieved from our CON‐PAS registry on conservative management using uterine artery embolization (23 studies), 27‐49 prophylactic balloon placement (15 studies), 2,50‐63 compression sutures (10 studies), 8,64‐72 leaving the placenta in situ (7 studies), 10,73‐78 and uterine wall excision and reconstruction (6 studies) 79‐84 . Despite the number of conducted studies (61 studies, 1979 patients), they have not yielded robust evidence‐based recommendations.…”

Section: Discussionmentioning

confidence: 99%

High‐intensity focused ultrasound in management of placenta accreta spectrum: A systematic review

Elazeem

Saad

Ahmed

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Background: High-intensity focused ultrasound (HIFU) is a non-invasive procedure that has been studied in the management of placenta accreta spectrum (PAS). Objective: To appraise HIFU in the management of PAS and highlight the restrictions on converting uterus-preserving studies into evidence-based practice. Search strategy: A search on Scopus, Cochrane, PubMed and Web of Science was conducted from date of inception to January 2020. Selection criteria: Studies on using HIFU in the management of PAS were eligible. Review articles, conference papers, and case reports were excluded. Data collection: A standardized sheet was used to abstract data from eligible studies. CON-PAS registry was used to include studies on other conservative modalities. Results: Four studies were eligible (399 patients). Average residual placental volume was 61.74 cm 3 (6.01-339 cm 3). Treatment was successful in all patients. Normal menstruation recovered after 48.8 days (15-150 days). No major complications were encountered. Sixty-one studies were retrieved from the CON-PAS registry; uterine artery embolization (23 studies), balloon placement (15 studies), compression sutures (10 studies), placenta in situ (7 studies), and uterine resection (6 studies) were successful in 83.7%, 92.9%, 87.9%, 85.2%, and 79.3% of cases, respectively. Conclusions: HIFU may fit certain clinical situations in the management of PAS. A global research strategy is recommended to incorporate conservative approaches within a comprehensive management protocol.

show abstract

Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy

Cited by 26 publications

References 14 publications

FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,

FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,

PACCRETA: Clinical situations at high risk of Placenta ACCRETA/Percreta: impact of diagnostic methods and management on maternal morbidity

High‐intensity focused ultrasound in management of placenta accreta spectrum: A systematic review

Contact Info

Product

Resources

About